Medical Equipment
Merck Drives New Innovation & Adds Capacity to Advance Next Generation Antibody-drug Conjugate (ADC) Therapies
- Merck's unique technology, ChetoSensar™, gives new promise to ADCs by alleviating solubility challenges - New DOLCORE™ platform increases speed-to-market by up to a year - Expanded ADC clinical manufacturing facility drives next generation ADCs, building on company's 15 years of ADC Contract...
2021-10-28 21:00
3335
Interim report for Q3 2021 : Bactiguard Holding AB (publ)
STOCKHOLM, Oct. 28, 2021 /PRNewswire/ -- Capital injection initiates a new phase of accelerated expansion Third quarter (July-September 2021) * Revenues amounted to SEK 45.2 (34.1) million, an increase of 32%. Adjusted for currency effects revenues increased by 36%. * EBITDA amounted to SEK ...
2021-10-28 15:23
1998
Mentice publishes the company's interim report for the period January-September 2021
STOCKHOLM, Oct. 28, 2021 /PRNewswire/ -- Third quarter (July–September 2021) and the first nine months of the year (January-September 2021) * Order intake amounted to 51.8 (34.6) MSEK for the third quarter and 131.9 (95.5) MSEK for the first nine months of the year. * Order book by the end ...
2021-10-28 15:07
1735
Ingersoll Rand and its Brands Support the Public Health in the Post-Pandemic Era
SINGAPORE, Oct. 27, 2021 /PRNewswire/ -- Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and industrial solutions, is providing compressed air and vacuum, material handling, and metering solutions to the medical and pharmaceutical industries. Its cutting-edge co...
2021-10-28 05:47
3570
HT Supreme® Drug Eluting Stent performs equivalent to best-in-class in the PIONEER III publication
TIANJIN, China, Oct. 27, 2021 /PRNewswire/ -- SINOMED, a leading international medical device company, announced that the clinical trial results for its HT Supreme® Drug-Eluting Stent (DES) System has been published in Circulation. The article described results from the PIONEER III trial where i...
2021-10-27 15:00
3093
Haier's HCH Ventures Partners with RF Imaging Leader Vayyar to Establish Joint Venture in China
The Joint Venture partnership will initially focus on providing touchless fall detection for seniors as well as expanding Vayyar's activities in the Chinese market - HCH, a subsidiary of Haier, signs Joint Venture agreement with Israeli technology provider, Vayyar, aiming to address the4 trillio...
2021-10-27 14:00
3802
Elekta receives initial investment grade rating from S&P Global Ratings
STOCKHOLM, Oct. 26, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has received an investment grade (IG) rating from S&P Global Ratings (S&P). S&P has assigned a BBB- rating to Elekta and to the Group's senior unsecured notes, with stable outlook. S&P notes that Elekta's rating r...
2021-10-26 20:50
2046
Introducing Prodigy for Improved Peptide Purification
-- Improved resolution and separation of peptide impurities -- Easier purification of hydrophobic peptides -- Direct transfer from analytical to preparative scale MATTHEWS, N.C., Oct. 26, 2021 /PRNewswire/ -- CEM Corporation is proud to announce the release of the new Prodigy™ Preparative High-P...
2021-10-26 20:28
3904
Medigate Launches Clinical Device Efficiency to Improve Operational Efficiency for HDOs
The new offering from the medical device cybersecurity leader aims to increase medical device visibility, streamline hospital workflows, and reduce costs BROOKLYN, N.Y., Oct. 26, 2021 /PRNewswire/ -- Medigate, creator of the industry's first and leading healthcare-specific platform to orchestrate...
2021-10-26 20:00
1758
Farrer Park Hospital Offers Transcatheter Aortic Valve Implantation (TAVI)
SINGAPORE, Oct. 25 , 2021 /PRNewswire/ -- Farrer Park Hospital ("FPH") offers TAVI as an alternative treatment option for those suffering from aortic valve stenosis who are elderly or for younger patients who are not suitable for open-heart surgery. In aortic valve stenosis, the aortic valve sit...
2021-10-25 13:09
2683
Meet the Next Resolution in Medicine -- Polaris Biology Releases Starion™, the next-generation mass cytometer
SHANGHAI, Oct. 23, 2021 /PRNewswire/ -- Polaris Biology, a leading innovator in
single-cell technologies, announced today the largest product launch in company
history with the introduction of the Starion™ Mass Cytometry System.
2021-10-23 15:05
3257
Speclipse included in MedTech Outlook rating of top 10 non-invasive device companies
SEOUL, South Korea, Oct. 21, 2021 /PRNewswire/ -- Speclipse, a startup
specializing in laser spectroscopic and AI-based medicaldiagnostic technologies
and a member ofBorn2Global Centre, was recently included in MedTech Outlook's
"Top 10 Non InvasiveDevice Companies" ranking for 2021.
2021-10-21 21:00
7149
Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on October 28 at 9:30 CEST
STOCKHOLM, Oct. 21, 2021 /PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFOGunilla Andersson. To register for the presentation of ...
2021-10-21 16:28
1917
Guangzhou Concord Cancer Center Becomes a Designated Hospital of Social Healthcare Insurance
BEIJING, Oct. 21, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone ...
2021-10-21 16:00
9067
A Hypercompact CRISPR Technology Developed by GenKOre is deemed a Potential Game Changer in Gene Therapy.
DAEJEON, South Korea, Oct. 20, 2021 /PRNewswire/ -- On September 2, 2021, a
scientific paper from GenKOre on the new hypercompact CRISPR system called
CRISPR/Cas12f-GE was published in an online issue of Nature Biotechnology (IF
54.9), one of the world's top-tier biotechnology journals.
2021-10-21 09:05
1701
EVERSANA and Intouch Group join forces, adding the premiere digital-first agency network to the market leader in next generation commercialization
CHICAGO and KANSAS CITY, Mo., Oct. 20, 2021 /PRNewswire/ -- EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, andIntouch Group®, a full-service global agency network serving the pharmaceutical industry, today announced that they signed an agreemen...
2021-10-20 22:34
4123
A Hypercompact CRISPR Technology Developed by GenKOre is deemed a Potential Game Changer in Gene Therapy.
DAEJEON, South Korea, Oct. 20, 2021 /PRNewswire/ -- On September 2, 2021, a
scientific paper from GenKOre on the new hypercompact CRISPR system called
CRISPR/Cas12f-GE was published in an online issue of Nature Biotechnology (IF
54.9), one of the world's top-tier biotechnology journals.
2021-10-20 15:31
3677
Getinge Q3 Report 2021: "Strong order intake and our remediation measures completed in Germany"
GOTHENBURG, Sweden, Oct. 20, 2021 /PRNewswire/ -- "Organic order intake increased by more than 20% in the third quarter, with a strong performance in all business areas and regions," says Mattias Perjos, President & CEO at Getinge. "Our cash flow remains strong, meaning that we have strengthened ...
2021-10-20 15:19
3907
Phillips-Medisize Increases Global Manufacturing Capacity, Capabilities and Collaborations to Drive Drug Delivery, Diagnostic and MedTech Innovations
- Medical and pharmaceutical solutions leader poised to scale manufacturing from new and expanded production facilities and R&D centers inPoland, China and U.S. - End-to-end capabilities optimize design, development and manufacturing of world-class healthcare products and solutions while reducin...
2021-10-20 10:00
3360
Alterity Therapeutics Announces Expanded ATH434 Phase 2 Clinical Development Program
- Clinical trial to enroll patients with early-stage Multiple Systems Atrophy (MSA) - - Expanding bioMUSE Natural History Study - MELBOURNE, Australia and SAN FRANCISCO, Oct. 19, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology c...
2021-10-20 05:08
2152
Week's Top Stories
Most Reposted
Agoda Launches Agoda Impact Lab at ASEAN Tourism Forum
[Picked up by 318 media titles]
2026-01-29 15:06
Wonder Raises USD 12 Million Venture Debt from HSBC Innovation Banking to Drive Growth and Expansion
[Picked up by 315 media titles]
2026-02-02 10:00
Agoda Launches Open-Source API Agent to Simplify MCP Server Integrations
[Picked up by 309 media titles]
2026-01-27 13:00
Nokia Strengthens Edge AI Capabilities Through Strategic Collaboration with Blaize on Hybrid Inference Solutions Across Asia Pacific Regions
[Picked up by 294 media titles]
2026-01-27 18:00
Singapore Airshow 2026 Milestone Edition: 20 Years of Shaping the Aerospace Landscape as Asia-Pacific Drives Global Growth
[Picked up by 284 media titles]
2026-02-01 19:35